Cytohormonal studies in patients with endometrial hyperplasia
Polishchuk, L.Z.; Buchinskaia, L.G.; Vinnichenko, V.N.
Akusherstvo i Ginekologiia 9: 67-69
1986
ISSN/ISBN: 0300-9092 PMID: 2947506 Document Number: 285777
Document emailed within 1 workday
Related Documents
Prakansamut, N.; Sirayapiwat, P.; Triratanachat, S. 2014: The percentages of endometrial hyperplasia and endometrial cancer among polycystic ovary syndrome (PCOS) patients presenting with abnormal menstrual pattern Journal of the Medical Association of Thailand 97(2): 159-164Lindahl, B.; Willén, R. 1994: Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years Anticancer Research 14(5b): 2141-2146
Siiteri, P.K. 1980: Hormonal characteristics of patients with endometrial hyperplasia and carcinoma Acta Cytologica 24(6): 482-483
Meissner, W.A.; Sommers, S.C.; Sherman, G. 1957: Endometrial hyperplasia, endometrial carcinoma, and endometriosis produced experimentally by estrogen Cancer 10(3): 500-509
Greenwood, S.M. 1976: The relation of adenomyosis uteri to coexistent endometrial carcinoma and endometrial hyperplasia Obstetrics and Gynecology 48(1): 68-72
Rzepka-Górska, I.; Bedner, R.; Cymbaluk-Płoska, A.; Chudecka-Głaz, A. 2008: Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women European Journal of Gynaecological Oncology 29(6): 594-597
Stachowicz, N.; Czekierdowski, A.; Daniłoś, Jław.; Smoleń, A.; Kotarski, J. 2005: Three-dimensional sonoangiography in diagnostic of endometrial hyperplasia and carcinoma. An assessment of vascularization indices and endometrial volume Przeglad Lekarski 62(9): 827-829
Jesadapatrakul, S.; Tangjitgamol, S.; Manusirivitaya, S. 2005: Histopathologic consistency between endometrial hyperplasia diagnosis from endometrial curettage and pathologic diagnoses from hysterectomy specimens Journal of the Medical Association of Thailand 88(Suppl 2): S16-S21
Sasaki, H. 1993: Aromatase activities of endometrial carcinomas and both basic and clinical analyses of endometrial hyperplasia as a premalignant disease Nihon Sanka Fujinka Gakkai Zasshi 45(8): 763-775
Borisov, I.; Maĭnkhard, K.; Tsankova, M. 1996: The relationship between simple and atypical endometrial hyperplasia and endometrial carcinoma Akusherstvo i Ginekologiia 35(4): 18-20
Szamborski, J.; Teter, J.; Wasilewska, B. 1985: Endometrial hyperplasia detected by ambulatory endometrial biopsy Patologia Polska 36(1): 47-57
Sato, S. 1993: Evaluation of the degree of biological behavior in endometrial hyperplasia and endometrial carcinoma: an investigation of proliferative activity, oncogene, and extracellular matrix Nihon Sanka Fujinka Gakkai Zasshi 45(8): 776-788
Anastasiadis, P.G.; Skaphida, P.G.; Koutlaki, N.G.; Galazios, G.C.; Tsikouras, P.N.; Liberis, V.A. 2000: Descriptive epidemiology of endometrial hyperplasia in patients with abnormal uterine bleeding European Journal of Gynaecological Oncology 21(2): 131-134
Volpe, A.; Botticelli, A.; Abrate, M.; Dalla Vecchia, E.; Mantovani, M.; Carani, C.; Grasso, A.; Mazza, V.; Di Renzo, G.C. 1982: An intrauterine progesterone contraceptive system (52 mg) used in pre- and peri-menopausal patients with endometrial hyperplasia Maturitas 4(1): 73-79
Socolov, D.; Socolov, R.; Lupascu, I.A.; Rugina, V.; Gabia, O.; Garauleanu, D.M.; Carauleanu, A. 2016: Immunohistochemistry in Endometrial Hyperplasia and Endometrial Adenocarcinoma Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 120(2): 355-362
Namiki, T. 1979: Pathology of endometrial hyperplasia and endometrial carcinoma Rinsho Byori. Japanese Journal of Clinical Pathology 27(11): 1020-1025
Semiglazov, V.F.; Maximov, S.Y.; Bulgatova, Y., A.; Meshkova, I.Y.; Chepik, O.F.; Berstein, L.M. 2003: Risk of hyperplasia and endometrial carcinoma in breast cancer patients receiving adjuvant tamoxifen Voprosy Onkologii (Stsburg). 49(2): 198-204
Lin, M.; Xu, X.; Wang, Y.; Hu, Y.; Zhao, Y. 2014: Evaluation of a levonorgestrel-releasing intrauterine system for treating endometrial hyperplasia in patients with polycystic ovary syndrome Gynecologic and Obstetric Investigation 78(1): 41-44
Vereide, A.B.; Arnes, M.; Straume, B.; Maltau, J.M.; Ørbo, A. 2003: Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone Gynecologic Oncology 91(3): 526-533
Vereide, A.B.; Kaino, T.; Sager, G.; Ørbo, A. 2005: Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone Gynecologic Oncology 97(3): 740-750